Literature DB >> 28930961

Impact of a novel phosphoinositol-3 kinase inhibitor in preventing mitochondrial DNA damage and damage-associated molecular pattern accumulation: Results from the Biochronicity Project.

George Edward Black1, Kyle K Sokol, Donald M Moe, Jon D Simmons, David Muscat, Victor Pastukh, Gina Capley, Olena Gorodnya, Mykhaylo Ruchko, Mark B Roth, Mark Gillespie, Matthew J Martin.   

Abstract

BACKGROUND: Despite improvements in the management of severely injured patients, development of multiple organ dysfunction syndrome (MODS) remains a morbid complication of traumatic shock. One of the key attributes of MODS is a profound bioenergetics crisis, for which the mediators and mechanisms are poorly understood. We hypothesized that metabolic uncoupling using an experimental phosphoinositol-3 kinase (PI3-K) inhibitor, LY294002 (LY), may prevent mitochondrial abnormalities that lead to the generation of mitochondrial DNA (mtDNA) damage and the release of mtDNA damage-associated molecular patterns (DAMPs).
METHODS: Sixteen swine were studied using LY, a nonselective PI3-K inhibitor. Animals were assigned to trauma only (TO, n = 3), LY drug only (LYO, n = 3), and experimental (n = 10), trauma + drug (LY + T) groups. Both trauma groups underwent laparotomy, 35% hemorrhage, severe ischemia-reperfusion injury, and protocolized resuscitation. A battery of hemodynamic, laboratory, histological, and bioenergetics parameters were monitored. Mitochondrial DNA damage was determined in lung, liver, and kidney using Southern blot analyses, whereas plasma mtDNA DAMP analysis used polymerase chain reaction amplification of a 200-bp sequence of the mtDNA D-loop region.
RESULTS: Relative to control animals, H + I/R (hemorrhage and ischemia/reperfusion) produced severe, time-dependent decrements in hepatic, renal, cardiovascular, and pulmonary function accompanied by severe acidosis and lactate accumulation indicative of bioenergetics insufficiency. The H-I/R animals displayed prominent oxidative mtDNA damage in all organs studied, with the most prominent damage in the liver. Mitochondrial DNA damage was accompanied by accumulation of mtDNA DAMPs in plasma. Pretreatment of H + I/R animals with LY resulted in profound metabolic suppression, with approximately 50% decreases in O2 consumption and CO2 production. In addition, it prevented organ and bioenergetics dysfunction and was associated with a significant decrease in plasma mtDNA DAMPs to the levels of control animals.
CONCLUSIONS: These findings show that H + I/R injury in anesthetized swine is accompanied by MODS and by significant mitochondrial bioenergetics dysfunction, including oxidative mtDNA damage and accumulation in plasma of mtDNA DAMPs. Suppression of these changes with the PI3-K inhibitor LY indicates that pharmacologically induced metabolic uncoupling may comprise a new pharmacologic strategy to prevent mtDNA damage and DAMP release and prevent or treat trauma-related MODS. LEVEL OF EVIDENCE: Therapeutic study, level III.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28930961      PMCID: PMC5938741          DOI: 10.1097/TA.0000000000001593

Source DB:  PubMed          Journal:  J Trauma Acute Care Surg        ISSN: 2163-0755            Impact factor:   3.313


  39 in total

1.  Survival in critical illness is associated with early activation of mitochondrial biogenesis.

Authors:  Jane E Carré; Jean-Christophe Orban; Lorenza Re; Karen Felsmann; Wiebke Iffert; Michael Bauer; Hagir B Suliman; Claude A Piantadosi; Terry M Mayhew; Patrick Breen; Martin Stotz; Mervyn Singer
Journal:  Am J Respir Crit Care Med       Date:  2010-06-10       Impact factor: 21.405

Review 2.  Targeting phosphoinositide 3-kinase: moving towards therapy.

Authors:  Romina Marone; Vladimir Cmiljanovic; Bernd Giese; Matthias P Wymann
Journal:  Biochim Biophys Acta       Date:  2007-10-12

3.  Mitochondrial-targeted DNA repair enzyme 8-oxoguanine DNA glycosylase 1 protects against ventilator-induced lung injury in intact mice.

Authors:  Masahiro Hashizume; Marc Mouner; Joshua M Chouteau; Olena M Gorodnya; Mykhaylo V Ruchko; Barry J Potter; Glenn L Wilson; Mark N Gillespie; James C Parker
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-12-14       Impact factor: 5.464

Review 4.  Redox regulation of mitochondrial biogenesis.

Authors:  Claude A Piantadosi; Hagir B Suliman
Journal:  Free Radic Biol Med       Date:  2012-09-19       Impact factor: 7.376

5.  Inhibition of phosphatidylinositol 3-kinase/AKT signaling by NVP-BKM120 promotes ABT-737-induced toxicity in a caspase-dependent manner through mitochondrial dysfunction and DNA damage response in established and primary cultured glioblastoma cells.

Authors:  Esther P Jane; Daniel R Premkumar; Alejandro Morales; Kimberly A Foster; Ian F Pollack
Journal:  J Pharmacol Exp Ther       Date:  2014-04-16       Impact factor: 4.030

6.  Role of nitric oxide-induced mtDNA damage in mitochondrial dysfunction and apoptosis.

Authors:  Lyudmila I Rachek; Valentina I Grishko; Susan P Ledoux; Glenn L Wilson
Journal:  Free Radic Biol Med       Date:  2005-10-18       Impact factor: 7.376

7.  Causes of death in U.S. Special Operations Forces in the global war on terrorism: 2001-2004.

Authors:  John B Holcomb; Neil R McMullin; Lisa Pearse; Jim Caruso; Charles E Wade; Lynne Oetjen-Gerdes; Howard R Champion; Mimi Lawnick; Warner Farr; Sam Rodriguez; Frank K Butler
Journal:  Ann Surg       Date:  2007-06       Impact factor: 12.969

8.  Plasma mitochondrial DNA levels in patients with trauma and severe sepsis: time course and the association with clinical status.

Authors:  Satoshi Yamanouchi; Daisuke Kudo; Mitsuhiro Yamada; Noriko Miyagawa; Hajime Furukawa; Shigeki Kushimoto
Journal:  J Crit Care       Date:  2013-06-18       Impact factor: 3.425

9.  Oxidative stress induces degradation of mitochondrial DNA.

Authors:  Inna Shokolenko; Natalia Venediktova; Alexandra Bochkareva; Glenn L Wilson; Mikhail F Alexeyev
Journal:  Nucleic Acids Res       Date:  2009-03-05       Impact factor: 16.971

10.  Modulating effect of the PI3-kinase inhibitor LY294002 on cisplatin in human pancreatic cancer cells.

Authors:  Masao Fujiwara; Kunihiko Izuishi; Takanori Sano; Mohammad Akram Hossain; Shoji Kimura; Tsutomu Masaki; Yasuyuki Suzuki
Journal:  J Exp Clin Cancer Res       Date:  2008-11-25
View more
  3 in total

Review 1.  Optimizing transfusion strategies in damage control resuscitation: current insights.

Authors:  Timothy H Pohlman; Alison M Fecher; Cecivon Arreola-Garcia
Journal:  J Blood Med       Date:  2018-08-20

2.  Immunogenic Cell Death-Relevant Damage-Associated Molecular Patterns and Sensing Receptors in Triple-Negative Breast Cancer Molecular Subtypes and Implications for Immunotherapy.

Authors:  Ming Xu; Jin-Hua Lu; Ya-Zhen Zhong; Jing Jiang; Yue-Zhong Shen; Jing-Yang Su; Sheng-You Lin
Journal:  Front Oncol       Date:  2022-04-04       Impact factor: 5.738

Review 3.  Novel Targets and Therapeutic Strategies to Protect Against Hepatic Ischemia Reperfusion Injury.

Authors:  Xin-Li Mao; Yue Cai; Ya-Hong Chen; Yi Wang; Xiu-Xiu Jiang; Li-Ping Ye; Shao-Wei Li
Journal:  Front Med (Lausanne)       Date:  2022-01-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.